Common Data Elements: Making the Mass of NIH Measures More Useful
|
|
- Christian Dorsey
- 5 years ago
- Views:
Transcription
1 Common Data Elements WG Common Data Elements: Making the Mass of NIH Measures More Useful Jerry Sheehan Assistant Director for Policy Development Na?onal Library of Medicine Gene/c Alliance Webinar Series 09 July 2014
2 Common Data Elements WG SeXng the Stage Growing Mass of Biomedical Data Biomedical research is increasingly data- intensive and data- driven By one es/mate, NIH- funded research generates ~ 115,000 research papers per year ~ 3 data sets per paper (range in sample: 1-120) => ~ 445,000 new data sets per year Human subjects research ~ 25% = 110,000 data sets Mul/ple variables per data set 7/9/2014 Gene/c Alliance Webinar 2
3 Common Data Elements WG Growing Numbers of Data Elements & Measures dbgap 488 Studies 3,159 datasets 145,000 variables ClinicalTrials.gov - 19,000 studies registered per year Total of 170,000+ studies; 13,000+ with results Mul/ple outcome measures per trial (primary and secondary) Primary: median = 1 (max = 82) Secondary: median = 4 (max = 172) E.g., depression measured in > 4500 studies 888 Hamilton Depression Ra/ng Scale 718 Beck Depression Inventory 511 Montgomery Asberg Depression Ra/ng Scale 111 PHQ 9 Many, many others cadsr 46,000+ data elements Depression 118 data elements (some components of Beck, Hamilton, etc.) Smoking 192 data elements 7/9/2014 Gene/c Alliance Webinar 3
4 What is a Common Data Element (CDE)? Common Data Elements WG Common Data Elements as a Solu/on Fixed representa/on of a variable to be collected and analyzed in projects within a par/cular analy/c or clinical domain. Consists of a precisely defined ques/on and a specified format or set of permissible values for responses (answers). Ideally, a CDE is defined unambiguously in both human and machine- computable terms. Sets of CDEs can be combined into more complex ques/onnaires, survey instruments, and case report forms. 7/9/2014 Gene/c Alliance Webinar 4
5 Why Common Data Elements? Common Data Elements WG Facilitate cross- study comparison of results Enable aggrega/on of data from mul/ple studies greater sta/s/cal power, detect weaker signals Speed study start up by selec/ng from exis/ng measures, instruments Improve data quality via use of validated measures Improve replica/on and reproducibility 7/9/2014 Gene/c Alliance Webinar 5
6 Common Data Elements WG NIH CDE Efforts Several NIH ICs iden/fying common data elements NIH CDE Working Group established to improve coordina?on & communica?on of efforts to iden?fy, develop, & promote use of CDEs across NIH Develop Web portal of NIH CDE resources Encourage use of CDEs by funded inves/gators Reduce overlap, redundancy, and near misses among selected data elements Improve interoperability and compa/bility with other standards development ac/vi/es (e.g., other HHS standards, meaningful use of EHRs) Assist NIH staff and inves/gators in iden/fying and using relevant CDEs Almost 40 WG members from 22 ICs 7/9/2014 Gene/c Alliance Webinar 6
7 Common Data Elements WG NIH Common Data Element Resources CDE Ini<a<ves Standardized data elements, data collec/on instruments, lab tests, etc. Primarily for use in funded clinical research, pa/ent registries, surveillance Entail a vexng processes for selec/on Experimental valida/on Expert opinion What to collect and how to collect it CDE Tools & Resources Databases and repositories of data elements and case report forms Used in funded clinical research, pa/ent registries, surveillance Limited vexng of content Selec/on criteria Metadata standards Provide broad sets of examples of how data are collected May include tools to assist inves/gators in iden/fying and selec/ng data elements 7/9/2014 Gene/c Alliance Webinar 7
8 NIH CDE Ini/a/ves Common Data Elements WG 7/9/2014 Gene/c Alliance Webinar 8
9 NIH CDE Tools & Resources Common Data Elements WG 7/9/2014 Gene/c Alliance Webinar 9
10 hcp://cde.nih.gov Launched in January 2013 Links from BMIC, OER Sharing, and CDE IniBaBves web pages 7/9/2014 Gene/c Alliance Webinar 10
11 7/9/2014 Gene/c Alliance Webinar 11
12 7/9/2014 Gene/c Alliance Webinar 12
13 7/9/2014 Gene/c Alliance Webinar 13
14 Common Data Elements WG NINDS CDE Example: TBI Assessments & Examina/ons 7/9/2014 Gene/c Alliance Webinar 14
15 Common Data Elements WG NINDS CDE Example: TBI Assessments & Examina/ons 7/9/2014 Gene/c Alliance Webinar 15
16 7/9/2014 Gene/c Alliance Webinar 16
17 Common Data Elements WG CDE Portal - Resource Summaries 7/9/2014 Gene/c Alliance Webinar 17
18 7/9/2014 Gene/c Alliance Webinar 18
19 7/9/2014 Gene/c Alliance Webinar 19
20 NIH CDE Challenges Common Data Elements WG Making poten/al users aware of NIH CDEs? Encouraging use of NIH CDEs beyond original, limited research domains? Harmonizing NIH CDEs with other exis/ng or emerging data elements and data standards Minimizing (eliminate?) overlap between and among CDE ini/a/ves within them too? Providing more convenient access to NIH (and other) CDEs 7/9/2014 Gene/c Alliance Webinar 20
21 Common Data Elements WG Ongoing Ac/vi/es - Summary ü Promote awareness and use of CDEs among stakeholders ü Ar/cles, presenta/ons to relevant communi/es to raise awareness ü Language in funding announcements and grants to encourage use ü Sharing Lessons Learned - good prac/ce in developing CDEs ü Coordinate among NIH CDE ini/a/ves ü Reduce overlap and near misses in NIH CDEs ü Encouraging consulta/on/collabora/on prior to new starts ü Collabora/on with HHS agencies & others ü FDA data standards in 59+ priority therapeu/c areas ü ONC strategic data capture (SDC) ini/a/ve (for EHRs) ü Sharing informa/on with COMET, OMERACT, etc., ü Provide more convenient access to CDEs ü Expand portal content (addi/onal CDE ini/a/ves) ü Provide access to underlying data elements (e.g., linking to centralized repository or federated system) 7/9/2014 Gene/c Alliance Webinar 21
22 Outreach to User Communi/es Common Data Elements WG 7/9/2014 Gene/c Alliance Webinar 22
23 Encouraging Use of NIH CDEs Common Data Elements WG In RFAs, NOAs, NIH Guide... Parkinson's Udall Centers of Excellence... must u/lize the NINDS Common Data Elements Resource when construc/ng data element forms. NINDS expects... Inves/gator Ini/ated Phase III trial[s] will use the NINDS Common Data Elements resource when construc/ng data collec/on forms. FITBIR A data sharing plan should include use of the TBI Common Data Elements NIDA strongly encourages inves/gators involved in human- subjects studies to incorporat[e] the measures from the Core and Specialty collec/ons, which are available in the Substance Abuse and Addic/on Collec/on... NCATS Organiza/ons who are establishing rare diseases pa/ent registries are strongly encouraged to use the [ORD]/Global Rare Diseases Pa/ent Registry Data Repository Common Data Elements... 7/9/2014 Gene/c Alliance Webinar 23
24 Common Data Elements WG Encouraging Broader Use - Template Language Use of Common Data Elements in NIH- funded Research NIH encourages the use of common data elements (CDEs) in basic, clinical, and applied research, pa?ent registries, and other human subject research to facilitate broader and more effec?ve use of data and advance research across studies. CDEs are data elements that have been iden?fied and defined for use in mul?ple data sets across different studies. Use of CDEs can facilitate data sharing and standardiza?on to improve data quality and enable data integra?on from mul?ple studies and sources, including electronic health records. NIH ICs have iden?fied CDEs for many clinical domains (e.g., neurological disease), types of studies (e.g. genome- wide associa?on studies (GWAS)), types of outcomes (e.g., pa?ent- reported outcomes), and pa?ent registries (e.g., the Global Rare Diseases Pa?ent Registry and Data Repository). NIH has established a Common Data Element (CDE) Resource Portal" ( hwp://cde.nih.gov/) to assist inves?gators in iden?fying NIH- supported CDEs when developing protocols, case report forms, and other instruments for data collec?on. The Portal provides guidance about and access to NIH- supported CDE ini?a?ves and other tools and resources for the appropriate use of CDEs and data standards in NIH- funded research. Inves?gators are encouraged to consult the Portal and describe in their applica?ons any use they will make of NIH- supported CDEs in their projects. 7/9/2014 Gene/c Alliance Webinar 24
25 Promulgate Lessons Learned Common Data Elements WG 1. Don t reinvent the wheel Use exis/ng DEs if possible 2. Don t work alone Coordinate with others 3. Use validated data elements/instruments when possible. 4. Use data elements that conform to exis/ng data standards and are freely available, whenever possible. 5. Engage full range of needed exper/se: domain experts, informa/cs experts, others 6. Plan ahead to update CDEs over /me 7. Gain support of the user community 8. Develop a communica/ons strategy 9. Develop policies to promote the use of CDEs 10. Monitor compliance and uptake 7/9/2014 Gene/c Alliance Webinar 25
26 Common Data Elements WG Big Data To Knowledge (BD2K) hcp://bd2k.nih.gov Research Use of Clinical Data Frameworks for Community Based Standards 13- NOV CBIIT Seminar Series 26
27 Common Data Elements WG Inter- agency collabora/on: FDA 7/9/2014 Gene/c Alliance Webinar 27
28 Common Data Elements WG 7/9/2014 Gene/c Alliance Webinar 28
29 Common Data Elements WG Inter- agency collabora/on: ONC 7/9/2014 Gene/c Alliance Webinar 29
30 ONC Structured Data Capture Ini<a<ve Conceptual Workflow 2 Finds form/template 1 4 Inputs data 3 Converts, populates & displays form xx 5 Caches data Actor Key Provider/ End User x John Doe x x x x 6 Stores/ EHR System transmits data 7 7/9/2014 Gene/c Alliance Webinar 30
31 Common Data Elements WG Other Opportuni/es for Collabora/on PCORNet Healthcare systems research collaboratory COMET (Core Outcome Measures for Effec/veness Trials) Other HHS (ARHQ, CDC... ) Others 7/9/2014 Gene/c Alliance Webinar 31
32 Common Data Elements WG Integrate with EHR Data Standards Match CDEs to standards and terminologies required for meaningful use of cer/fied EHRs (i.e., SNOMED, LOINC, RxNORM) Several NIH CDE ini/a/ves now mapped to LOINC (Logical Observa/on IDs, Names & Codes) NLM Value Set Authority Center (VSAC) for Quality Measures Facilitate research use of clinical records (see hwp://bd2k.nih.gov/bd2k_workshop/index.html) 7/9/2014 Gene/c Alliance Webinar 32
33 Coordinate To Reduce Overlap 7/9/2014 Gene/c Alliance Webinar 33
34 Common Data Elements WG Prototype Data Element Repository 7/9/2014 Gene/c Alliance Webinar 34
35 7/9/2014 Gene/c Alliance Webinar 35
36 7/9/2014 Gene/c Alliance Webinar 36
37 Common Data Elements WG Next Steps Iden/fy other relevant efforts Iden/fy gaps where are CDEs needed (disease areas, condi/ons) Con/nued outreach Examine usage and impact Further development of repository and other tools Processes for harmoniza/on and integra/on 7/9/2014 Gene/c Alliance Webinar 37
38 Addi/onal Informa/on Common Data Elements WG CDE Web Portal hwp://cde.nih.gov BMIC Website hwp://nlm.nih.gov/nihbmic BD2K Website hwp://bd2k.nih.gov NLM Website hwp:// 7/9/2014 Gene/c Alliance Webinar 38
Welcome! Pragmatic Clinical Studies. David Hickam, MD, MPH Program Director Clinical Effectiveness Research. David Hickam, MD, MPH
Pragmatic Clinical Studies David Hickam, MD, MPH Program Director Clinical Effec2veness Research June 23, 2015 Welcome! David Hickam, MD, MPH Program Director Clinical Effectiveness Research 2 In this
More informationA review of approaches to identifying patient phenotype cohorts using electronic health records
A review of approaches to identifying patient phenotype cohorts using electronic health records Shivade, Raghavan, Fosler-Lussier, Embi, Elhadad, Johnson, Lai Chaitanya Shivade JAMIA Journal Club March
More informationThe PhenX Toolkit: Standard Measures for Collaborative Research
The PhenX Toolkit: Standard Measures for Collaborative Research Clinical Common Data Elements Task Force (CDETF) November 4, 2016 Carol M. Hamilton, PhD RTI International is a trade name of Research Triangle
More informationTHE RARE DISEASES CLINICAL RESEARCH NETWORK AS A NESTED CULTURAL COMMONS
THE RARE DISEASES CLINICAL RESEARCH NETWORK AS A NESTED CULTURAL COMMONS Bre5 Frischmann, Benjamin N. Cardozo School of Law Katherine J. Strandburg, NYU School of Law Can Cui, NYU School of Law Case study
More informationSession 13 Objec+ves MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012
2012 MSDA Na+onal Medicaid and CHIP Oral Health Symposium June 24 th 26 th, 2012 Session 13 Dental Quality Alliance Update Krishna Aravamudhan, BDS, MS (DQA) Martha Dellapena (MSDA) Session 13 Objec+ves
More informationOhio Medical Marijuana Control Program
Ohio Medical Marijuana Control Program Guiding Principles Ohio Medical Marijuana Control Program is: 1. Pa;ent-centered and safe 2. Responsive, data-driven, and transparent 3. Flexible, scalable, and sustainable
More informationBiobanking in Finland
Biobanking in Finland Anu Jalanko 28.11.2016 1 Major Health reform in Finland The government has published dra4 bills on health, social services and regional government reform One of the largest ever administra9ve
More informationJosep M Borras WP7 Health Care University of Barcelona and Spanish Cancer Strategy Brussels, June 23, 2014
THE IMPORTANCE OF SHARING EXPERTISE AND THE CHALLENGE TO MANAGE THE EXCHANGE OF KNOWLEDGE IN HIGHLY SPECIALISED HEALTH CARE: a perspec(ve from the European Partnership Ac(on Against Cancer (EPAAC) Josep
More informationThe Canadian Landscape of PaAent Reported Outcome and Experience Measures. Santana MJ, MPharm, PhD October 17, 2016, Amsterdam
The Canadian Landscape of PaAent Reported Outcome and Experience Measures Santana MJ, MPharm, PhD October 17, 2016, Amsterdam Canada & Netherlands: The Tulip Legacy Outline Overview -- Na+onal strategy
More informationDevelopment and Applica0on of Real- Time Clinical Predic0ve Models
Development and Applica0on of Real- Time Clinical Predic0ve Models Ruben Amarasingham, MD, MBA Associate Professor, UT Southwestern Medical Center AHRQ- funded R24 UT Southwestern Center for Pa?ent- Centered
More informationNIDA Par9cipa9on in Major NIH Pain Consor9um Ini9a9ves
NIDA Par9cipa9on in Major NIH Pain Consor9um Ini9a9ves David A. Thomas, Ph.D. Deputy Director, Division of Clinical Neuroscience and Behavioral Research, Na9onal Ins9tute on Drug Abuse NIH Pain Consor9um
More informationCrea%ng an XXXX model for rare disease drug discovery: pu7ng people in the driver s seat
Crea%ng an XXXX model for rare disease drug discovery: pu7ng people in the driver s seat Sharon F. Terry President and CEO, Genetic Alliance Co-founder, PXE International Co-Principal Investigator, PCORnet
More informationeuropsychology & Aging Laborato
europsychology & Aging Laborato Field-testing multilingual clinical assessment using DDI standards David K. Johnson, PhD. University of Kansas K Epidemiology and the Development of Alzheimer s Disease
More informationLearning Objec1ves. Study Design Considera1ons in Clinical Pharmacy
9/28/15 Study Design Considera1ons in Clinical Pharmacy Ludmila Bakhireva, MD, PhD, MPH Pree Sarangarm, PharmD, BCPS Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal
More informationLearning Objec1ves. Study Design Strategies. Cohort Studies 9/28/15
9/28/15 Learning Objec1ves Describe the features, advantages and disadvantages of the observa1onal study designs Explain why the overall study design is important when evalua1ng studies & applying their
More informationResults Members Survey 2012
Results Members Survey 2012 Phil Sell October, 2012 Members Survey 2012 Survey open September 26 th to October 7 th Separate survey for non member conference par:cipants 199 members ( sample size 563)
More informationIMPAACT TB SCIENTIFIC COMMITTEE. Anneke C Hesseling: Chair Sharon Nachman: Interim Vice Chair IMPAACT Vice Chair
IMPAACT TB SCIENTIFIC COMMITTEE Anneke C Hesseling: Chair Sharon Nachman: Interim Vice Chair IMPAACT Vice Chair Goal Address cri>cal therapeu>c research gaps in the preven>on and treatment of tuberculosis
More informationOncology Care Model Overview
Oncology Care Model Overview Centers for Medicare & Medicaid Services Innova3on Center (CMMI) September 2017 Innova3on at CMS Center for Medicare & Medicaid Innova3on (Innova3on Center) Established by
More informationI, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association
I, Mary M. Langman, Director, Information Issues and Policy, Medical Library Association (MLA), submit this statement on behalf of MLA and the Association of Academic Health Sciences Libraries (AAHSL).
More informationPROPOSED WORK PROGRAMME FOR THE CLEARING-HOUSE MECHANISM IN SUPPORT OF THE STRATEGIC PLAN FOR BIODIVERSITY Note by the Executive Secretary
CBD Distr. GENERAL UNEP/CBD/COP/11/31 30 July 2012 ORIGINAL: ENGLISH CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY Eleventh meeting Hyderabad, India, 8 19 October 2012 Item 3.2 of
More informationMoving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support
Moving Family Health History & Genetic Test Result Data into the Electronic Health Record for Clinical Decision Support HL7 30 Years of Standards Development HIMSS February 21, 2017 Grant M. Wood Intermountain
More informationEffec&ve Messaging for Suicide Preven&on:
Effec&ve Messaging for Suicide Preven&on: Anara Guard anara@suicideispreventable.org Lessons from a statewide campaign and from a na&onal framework This morning The Know the Signs statewide social marke&ng
More informationForward Looking Statements
March 12, 2015 1 Forward Looking Statements This presenta5on contains forward- looking statements within the meaning of the Private Securi5es Li5ga5on Reform Act of 1995 that involve substan5al risks and
More informationMeaningful Use of Meaningful Use
Meaningful Use of Meaningful Use Kevin Larsen MD Medical Director, Meaningful Use Office of the Na;onal Coordinator of Health IT March 7 2013 Our Na;onal Quality Strategy Aims Be#er Health for the Popula0on
More informationPragma&c Clinical Trials
Pragma&c Clinical Trials Susanne May, PhD Associate Professor Department of Biosta&s&cs, School of Public Health, University of Washington Preliminaries PLEASE ask ques&ons at any &me REALLY good clinical
More informationA Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons?
A Trial Implementa.on of a High Density Health Informa.on Exchange Standard: Are We Ready for Coordinated Care in High Impact Condi.ons? Michael Hogarth, MD, FACP CMIO, Athena Breast Health Network Professor,
More informationSPF- SIG 101. Overview of SPF- SIG From the Na7onal Level, State Level and down to the Community Level
SPF- SIG 101 Overview of SPF- SIG From the Na7onal Level, State Level and down to the Community Level What is the SPF? Strategic Preven7on Framework Process is known to promote youth development, reduce
More informationThe Digital Age of HP2020
The Digital Age of HP2020 Theresa Devine, MPH Office of Disease Preven0on and Health Promo0on (HHS) Sarah Pomerantz, MPH CommunicateHealth, Inc. Ma5 Allen CommunicateHealth, Inc. This Morning s Agenda
More informationNa#onal HPV Vaccina#on Roundtable. Noel Brewer, Chair Debbie Saslow, Vice- Chair
Na#onal HPV Vaccina#on Roundtable Noel Brewer, Chair Debbie Saslow, Vice- Chair Mission The Na'onal HPV Vaccina'on Roundtable is a na'onal coali'on of public, private, and voluntary organiza'ons and invited
More informationRebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017
Rebooting Cancer Data Through Structured Data Capture GEMMA LEE NAACCR CONFERENCE JUNE, 2017 Acknowledgement Richard Moldwin, MD, PhD, CAP Sandy Jones, CDC Wendy Blumenthal, CDC David Kwan, Cancer Care
More informationMental Health, Substance Abuse & Primary Care: Bridging Gaps in Access
1 Mental Health, Substance Abuse & Primary Care: Bridging Gaps in Access Christopher Carroll, Director, Health Care Financing and Systems Integration Substance Abuse and Mental Health Services Administration
More informationNvLearn the Signs. Act Early. Au7sm and Referral March 27, Nevada Leadership Education In Neurodevelopmental and Related Disabilities
NvLearn the Signs. Act Early. Au7sm and Referral March 27, 2013 Nevada Leadership Education In Neurodevelopmental and Related Disabilities Acknowledgements Thank you to Centers for Disease Control for
More information3/31/2015. Designing Clinical Research Studies: So You Want to Be an
Designing Clinical Research Studies: So You Want to Be an Inves@gator Andrea Bonny, MD Ellen Lançon Connor, MD On behalf Of The NASPAG Research CommiPee Objec@ves Learn to design a clinical research project
More informationWebinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1
Webinar Series Its All About the Interac0on Strategies for Pragma2c Organiza2on of Communica2on Systems PART 1 Presented by: Jane Goetz, Au2sm Coordinator & Lori Chambers, Regional Systems Coordinator
More informationMedicare & Medicaid EHR Incentive Programs
Medicare & Medicaid EHR Incentive Programs Stage 2 NPRM Overview Robert Anthony March 6, 2012 Proposed Rule Everything discussed in this presentation is part of a notice of proposed rulemaking (NPRM).
More informationIn 2012, the HEARTH Act consolidated the three types of funding ac=vi=es in the McKinney Act (Suppor=ve Housing SHP, Shelter Plus Care and Sec=on 8
In 2012, the HEARTH Act consolidated the three types of funding ac=vi=es in the McKinney Act (Suppor=ve Housing SHP, Shelter Plus Care and Sec=on 8 Moderate Rehab SRO Program) and created one single program
More information2018 Conference on Ending Homelessness. Informa(onal Session Proposal Webinar
2018 Conference on Ending Homelessness Informa(onal Session Proposal Webinar Welcome To The Webinar Thank you for joining today s webinar! All par:cipants will be muted during the webinar to ensure good
More informationREPORT TO CONGRESS Multi-Disciplinary Brain Research and Data Sharing Efforts September 2013 The estimated cost of report or study for the Department of Defense is approximately $2,540 for the 2013 Fiscal
More informationBlue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results
Blue Cross Blue Shield of Michigan Building a Statewide PCMH Program: Design, Evalua>on Methods, and Results Margaret Mason, MHSA Michael Paus6an, PhD, MS Amanda Markovitz, MPH 1 Overview of BCBSM Serving
More informationPartnering with school- based. providers to improve HPV immunisa5on uptake in Victoria, Australia. Heather O Donnell December 2014
Partnering with school- based immunisa5on providers to improve HPV immunisa5on uptake in Victoria, Australia Heather O Donnell December 2014 Cervical screening & HPV immunisation, Australia! Public health
More informationIMPROVING GLOBAL ESTIMATES: PROCESS AND MILESTONES IATT Webinar June 7 th 2016
Where did we start? Where did we get to? Where do we want to go? IMPROVING GLOBAL ESTIMATES: PROCESS AND MILESTONES IATT Webinar June 7 th 2016 Mar6na Penazzato Paediatric advisor HIV Department WHO, Geneva-
More informationHRSA Ini)a)ves to Address Hepa))s C and Health Dispari)es September 7, 2017
HRSA Ini)a)ves to Address Hepa))s C and Health Dispari)es September 7, 2017 Letha Healey, MD Pamela Belton Sara Woody Division of Domes)c HIV Programs Office of Training and Capacity Development (OTCD)
More informationE. Scafato C. Gandin, L. Galluzzo, S. Ghirini, S. Martire, R. Scipione Istituto Superiore di Sanità, Italy
Guidelines to support early identification and brief interventions for alcohol use disorders in Europe: overview of RARHA survey results and of other EU projects E. Scafato C. Gandin, L. Galluzzo, S. Ghirini,
More informationBuilding an Effec.ve Advocacy Campaign
Building an Effec.ve Advocacy Campaign August 27, 2014 Bob Palmer, Policy Director Housing Ac7on Illinois Liz Kuoppala, Execu7ve Director Minnesota Coali7on for the Homeless TYPES OF CAMPAIGNS Public Bodies/Government
More informationInsights from CISCRP s 2017 Percep9ons & Insights Study March 2018
Insights from CISCRP s 2017 Percep9ons & Insights Study March 2018 Summary Overall public and patient attitudes, perceptions and experiences consistent with past studies Probing to identify underlying
More informationFindings from the At Home / Chez Soi Demonstration Project in Canada. Paula Goering and Catharine Hume May 2, 2013
Findings from the At Home / Chez Soi Demonstration Project in Canada Paula Goering and Catharine Hume May 2, 2013 Outline for today Overview of Project Design Na8onal level findings re one year outcomes
More informationDistrict Led Parent Training Series on Au4sm 10/6/14
Tri- State Au,sm Spectrum Disorder Webinar Series This presentation is a collaborative effort between the following: This material was developed under a grant from the Colorado Department of Education.
More informationNa#onal Trends in Addic#on Medicine. Ohio Chapter of the American Society of Addic4on Medicine 2017 Annual Mee4ng Wednesday, August 2, 2017
Na#onal Trends in Addic#on Medicine Ohio Chapter of the American Society of Addic4on Medicine 2017 Annual Mee4ng Wednesday, August 2, 2017 Ohio Chapter of the American Society of Addic4on Medicine 2017
More informationDesign, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research
Design, Conduct and Analysis of Pragma?c Clinical Trials in Pallia?ve Care Research Sco$ D. Halpern, M.D., Ph.D. Associate Professor of Medicine, Epidemiology, and Medical Ethics & Health Policy Director,
More informationRobin Feldman, MBA & Joy Esterlitz, MS NINDS CDE Team The Emmes Corporation Rockville, MD USA. Thursday, September 14, 2017
The National Institute of Neurological Disorders and Stroke (NINDS) and American Academy of Cerebral Palsy and Developmental Medicine (AACPDM) Cerebral Palsy Common Data Elements (CDE) Recommendations
More informationHealth Informa.cs. Lecture 9. Samantha Kleinberg
Health Informa.cs Lecture 9 Samantha Kleinberg samantha.kleinberg@stevens.edu Next week: journal club For all papers: read, and prepare to comment on For your paper: Read the ar.cle (+ other references
More informationImmunize. Prevent what s preventable Stakeholder Mee1ng.
Immunize. Prevent what s preventable. 2016 Stakeholder Mee1ng www.immunizeusa.org Housekeeping Facebook.com/immunizeusa @immunize_usa #BeHerdTX Evalua?ons White- TIP evalua?on Blue- CE evalua?on Trivia
More informationEconomic outcomes: Method for implementa5on
Economic outcomes: Method for implementa5on Philippe Beutels Centre for Health Economics Research & Modelling Infec
More information9/29/14 YEAR 1: SITUATIONAL ANALYSIS
HISTORY OF RECOVERY THE RECOVERY TO PRACTICE (RTP) INITIATIVE: EDUCATIONAL OPPORTUNITIES FOR THE RECOVERY-ORIENTED ADDICTION PROFESSIONAL Presented by Misti A. Storie, MS, NCC, APC September 30, 2014 o
More informationSta$s$cs, the Law, and the Future of Personalized Medicine. (What happened over spring break)
Sta$s$cs, the Law, and the Future of Personalized Medicine (What happened over spring break) Mayo v. Prometheus Prometheus Laboratories, Inc. developed a diagnos$c test for direc$ng treatment of immune-
More informationSemantic Alignment between ICD-11 and SNOMED-CT. By Marcie Wright RHIA, CHDA, CCS
Semantic Alignment between ICD-11 and SNOMED-CT By Marcie Wright RHIA, CHDA, CCS World Health Organization (WHO) owns and publishes the International Classification of Diseases (ICD) WHO was entrusted
More informationWelcome to Pa+ent Safety in Epilepsy Monitoring Units. Cosponsored by the American Epilepsy Society and the Na7onal Associa7on of Epilepsy Centers
Welcome to Pa+ent Safety in Epilepsy Monitoring Units Cosponsored by the American Epilepsy Society and the Na7onal Associa7on of Epilepsy Centers Overview of Educa+onal Program Web- based program designed
More informationA New Innova+ve Approach to Integrate Pa+ent Preferences into the Sta+s+cal Design for Clinical Trials: A Collabora+ve Case Study
A New Innova+ve Approach to Integrate Pa+ent Preferences into the Sta+s+cal Design for Clinical Trials: A Collabora+ve Case Study A Collabora)on of the Medical Device Innova)on Consor)um, FDA, MIT, RTI
More informationMaking Headlines: Promo2ng suicide preven2on with your local news media
Making Headlines: Promo2ng suicide preven2on with your local news media November 8, 2012 Welcome! Please mute your line If you have a ques2on, please type it into the Ques2ons box or raise your hand by
More informationDepartment of Emergency Office of Research. Shannon McNabb, MA, MPH Clinical Research Manager January 2017
Department of Emergency Medicine Office of Research Shannon McNabb, MA, MPH Clinical Research Manager January 2017 EM Study Tracking System UPDATED ON: 12/5/2016 TOTAL 68 Grants Submitted, Award Pending
More informationOffice of Training and Capacity Development AIDS Educa<on and Training Centers Overview
Office of Training and Capacity Development AIDS Educa
More informationAssessment of locomo,on ability
Université catholique de Louvain Cliniques universitaires St-Luc Département de Médicine Physique et de Réadapta,on Introduc,on Assessment of locomo,on ability Development of ABILOCO - ABILOCO-Kids Caty
More informationWHO posi)on paper on influenza vaccines*
WHO posi)on paper on influenza vaccines* Geneva, Switzerland Published in the Weekly Epidemiological Record on 23 November 2012 * This posi(on paper is concerned mainly with vaccines and vaccina(on against
More informationEHR Developer Code of Conduct Frequently Asked Questions
EHR Developer Code of Conduct Frequently Asked Questions General What is the purpose of the EHR Developer Code of Conduct? EHR Association (the Association) members have a long tradition of working with
More informationTBI Research at NIH. Ramona Hicks, PhD NIH/NINDS
TBI Research at NIH Ramona Hicks, PhD NIH/NINDS Objectives 1. Overview of TBI research opportunities at NIH 2. Highlight a few projects Common Data Element Project Federal Interagency TBI Research Informatics
More informationPreven&ng Pertussis: Current and Needed Strategies. June 16, PM 8PM
Preven&ng Pertussis: Current and Needed Strategies June 16, 2016 6PM 8PM Acknowledgements Agenda Welcome and Introduc&ons Epidemiology of Pertussis Essi M. Havor, MSN, APHN, RN Houston Health Department
More informationOverview of Provider and Patient Educational Resources
Overview of Provider and Patient Educational Resources Sonya Norman, PhD Director, PTSD Consulta3on Program, VA Na3onal Center for PTSD Associate Professor of Psychiatry, University of California, San
More informationUCRF Re- evalua,on. UNC Health Registry/Cancer Survivorship Cohort. April 16, 2014
UCRF Re- evalua,on UNC Health Registry/Cancer Survivorship Cohort April 16, 2014 Goals Create a cancer survivorship cohort of 10,000 pa,ents diagnosed and/or treated at UNC that focuses on cancers demonstra,ng
More informationSheesh, Problem behavior!
Crea%ng Communica%ve Competence through Func%onal Communica%on Training Jus*n Cooper Ed.D Robert Pennington Ph.D. BCBA- D Sheesh, Problem behavior! Challenging Behavior and Disabili%es Data suggest that
More informationSuccessful collaboration for research development between the NIH and patient organisations
Successful collaboration for research development between the NIH and patient organisations Stephen C. Groft, Pharm.D. Office of Rare Diseases s of Health Department of Health and Human Services EURORDIS
More informationConsumer Participation Strategy
Consumer Participation Strategy Plan Implementation Period 2011-2013 Date: 24 December 2010 Developed by: NEMICS Directorate in consultation with Acknowledgements and thank you to: s, Dr Ian Roos (Cancer
More informationspeakers! Jeffrey E. Shuren MD, JD Steven Immergut MPH Janet Woodcock MD Margaret Anderson Director, Center for Drug Evaluation and Research
Key FDA Programs! Objective: Describe FDA initiatives at CDER and CDRH to incorporate patient perspectives in decision-making and to articulate assessment of benefit-risk in a consistent manner across
More informationFinding and Using Local Data for Suicide Preven7on
Finding and Using Local Data for Suicide Preven7on January 21 st, 2014 1 Welcome! Please mute your phone or microphone line If you have a ques7on, please type it into the Ques7ons box or raise your hand
More informationA mul/disciplinary approach to early detect Neurodegenera/ve Langerhans Cell His/ocytosis and monitor response to intravenous immunoglobulin treatment
A mul/disciplinary approach to early detect Neurodegenera/ve Langerhans Cell His/ocytosis and monitor response to intravenous immunoglobulin treatment Elena Sieni, MD Department of Pediatric Hematology
More information2015 Na(onal Medicaid and CHIP Oral Health Symposium
MSDA Medicaid CHIP State Dental Association 2015 Na(onal Medicaid and CHIP Oral Health Symposium Session # 9 Primary Care Physician Integra(on into Dental Program An(cipatory Guidance, Screening & Care
More informationExperiential avoidance as a core process Overview of presentation:
Evaluation of the Avoidance and Fusion Questionnaire for Youth (AFQ-Y) - And Psychological Inflexibility in Adolescence Fredrik Livheim Licensed psychologist, Peer Reviewed ACT Trainer, project leader,
More informationEngaging Indigenous communities in health research
Engaging Indigenous communities in health research Josée G. Lavoie, Ongomiizwin Research, Indigenous Ins;tute of Health and Healing, University of Manitoba 1 2 Key messages Indigenous research requires
More informationClinical Research Project Design and Guidelines: Choosing a Research Ques8on
Clinical Research Project Design and Guidelines: Choosing a Research Ques8on Odunayo M. Oluwatosin, FMCS (Nig) Department of Plas?c Surgery University College Hospital Ibadan 1 Learning outcome: by the
More informationIndependence Well- being and Choice 2005, Our health, our care, our say 2006, Strong and Prosperous 2006
Medicines Op+misa+on Outcome focused approach to safe and effec+ve use of medicines that takes into account the pa+ent s values, percep+on and experience of taking their medicines Important Outcomes for
More informationENIGMA for Neurorehabilitation: A Large-Scale Meta-Analysis Approach to Modeling Neuroimaging, Genetics, and Behavior
ENIGMA for Neurorehabilitation: A Large-Scale Meta-Analysis Approach to Modeling Neuroimaging, Genetics, and Behavior Sook-Lei Liew, PhD, OTR/L Director, Neural Plasticity and Neurorehabilitation Laboratory
More informationIdentifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems
Identifying Engineering, Clinical and Patient's Metrics for Evaluating and Quantifying Performance of Brain- Machine Interface Systems Jose Pepe L. Contreras-Vidal, Ph.D. Department of Electrical & Computer
More information2015 Na(onal Medicaid and CHIP Oral Health Symposium. Integra(ng Oral and General Healthcare. Bruce Donoff, DMD, MD. Session #
MSDA Medicaid CHIP State Dental Association 2015 Na(onal Medicaid and CHIP Oral Health Symposium Session # Integra(ng Oral and General Healthcare Bruce Donoff, DMD, MD Washington Marrio4 Wardman Park Tuesday,
More informationJanuary Provider Wellness Commi3ee: A3 mid- year report
January Provider Wellness Commi3ee: A3 mid- year report January 20, 2016 UHA Provider Wellness Commi;ee Time: 12:30 1:30 PM LocaCon: 7999 Gateway Plaza, Newark Giants Conference Room & WebEx AGENDA ITEM
More informationRecrea&onal Therapy. Thomas K. Skalko, Ph.D., LRT/CTRS Chair, Commi<ee on Accredita&on of Recrea&onal Therapy Educa&on
Recrea&onal Therapy Thomas K. Skalko, Ph.D., LRT/CTRS Chair, Commi
More informationThe Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report
The Availability of Homeopathic Medicinal Products (HMPs) in Europe with reference to the Matrix Report A presenta@on to the European Parliament CAM Interest Group 1 July 2015 By Stephen Gordon General
More informationA Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research
A Transla)onal Framework for Methodological Rigor to Improve Pa)ent Centered Outcomes in End of Life Cancer Research Francesca Dominici, PhD Senior Associate Dean for Research Professor of Biostatistics
More informationTackling Tobacco Through Re-engineered Primary Care
2/27/18 Tackling Tobacco Through Re-engineered Primary Care Daren Wu, M.D. Chief Medical Officer Learning Objec>ves Understand the key stumbling blocks that can interfere with tobacco screening and treatment,
More informationAscendant Dx mission is to commercialize disruptive diagnostic technologies aiding diagnosis and treatment for diseases of women and children.
Ascendant Dx mission is to commercialize disruptive diagnostic technologies aiding diagnosis and treatment for diseases of women and children. Our particular focus is on cancer, autoimmune diseases and
More informationHealthy People A Resource for Promoting Health and Preventing Disease Throughout the Nation. Office of Disease Prevention and Health Promotion
Healthy People 2020 A Resource for Promoting Health and Preventing Disease Throughout the Nation Office of Disease Prevention and Health Promotion Healthy People Background and History What Is Healthy
More informationImpressions of a New NCI Director: Big Data
Impressions of a New NCI Director: Big Data Norman E. Sharpless, M.D. Cancer Informatics for Cancer Centers April 3, 2018 www.cancer.gov www.cancer.gov/espanol October 17, 2018 NCI: Leading the National
More informationBD-STEP: Tackling Key Issues Across Cancer Research and Care
BD-STEP: Tackling Key Issues Across Cancer Research and Care Michelle Berny-Lang, Ph.D. Program Director Center for Strategic Scientific Initiatives Office of the Director, National Cancer Institute BD-STEP
More information1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy
1. ATHENA Network, AVAC, and Salamander Trust with UN Women, undertook this mul>-stage review of the global status of access to an>retroviral therapy (ART) for women living with HIV 2. This is the first
More informationEnding Pandemics Ini.a.ve. Adam W. Crawley, MPH ISDS Webinar January 22, 2016
Ending Pandemics Ini.a.ve Adam W. Crawley, MPH ISDS Webinar January 22, 2016 Skoll Global Threats Ending Pandemics Our Approach Faster Detec0on and Repor0ng Through Novel Surveillance Systems Verifica0on
More informationAn Introduc+on to Cancer Care at Kaiser Permanente Northwest. Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line
An Introduc+on to Cancer Care at Kaiser Permanente Northwest Phoebe E. Harvey, MD Chief, Hematology/Oncology Medical Director, Cancer Service Line April 16, 2016 Agenda Overview and history of KP Northwest
More informationPaget s Disease of Bone
Paget s Disease of Bone Copyright Copyright 2019 American 2019 American Associa7on Associa7on of Clinical of Clinical Endocrinologists Endocrinologists 1 A Common Bone Disorder Paget s disease of bone
More informationDeveloping targeted therapies for neurodevelopmental and neurodegenerative diseases
Developing targeted therapies for neurodevelopmental and neurodegenerative diseases Clinical Pharmacokine/cs and Pharmacodynamics Characteriza/on of ANAVEX 2-73 for Designing a Phase 2/3 Study in Mild-to-Moderate
More informationCancer Control Council Evaluation and Monitoring Framework
Cancer Control Council Evaluation and Monitoring Framework Table of contents 1. Purpose...1 2. Background...1 3. Clarification of key tasks...2 4. International evaluation and monitoring frameworks...3
More informationSIMPATH Y. S*mula*ng Innova*on Management of Polypharmacy and Adherence in the Elderly Simpathy
S*mula*ng Innova*on Management of Sunfrail Transla1onal workshop Understanding and caring for frailty and mul1morbidity Bologna, March 22nd 2016 S*mula*ng Innova*on Management of Polypharmacy and Adherence
More informationReport on the Transplantation Transmission Sentinel Network (TTSN)
Report on the Transplantation Transmission Sentinel Network (TTSN) CATB Session - AATB s 31st Annual Meeting, Boston September 15, 2007 Scott Brubaker, CTBS AATB Representative, TTSN Advisory Group TTSN
More informationERN-Skin. With the support of the EADV
With the support of the EADV ERN-Skin Prof. C. Bodemer Head of the Department of Dermatology Hôpital Necker Enfants Malades President of the Genodermatoses & Rare Skin Disorders Network Scien8fic Commi;ee
More information